Cargando…
Hypoxia signaling in human diseases and therapeutic targets
Since the discovery of hypoxia-inducible factor (HIF), numerous studies on the hypoxia signaling pathway have been performed. The role of HIF stabilization during hypoxia has been extended from the induction of a single gene erythropoietin to the upregulation of a couple of hundred downstream target...
Autores principales: | Lee, Jae W., Ko, Junsuk, Ju, Cynthia, Eltzschig, Holger K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586801/ https://www.ncbi.nlm.nih.gov/pubmed/31221962 http://dx.doi.org/10.1038/s12276-019-0235-1 |
Ejemplares similares
-
Hypoxia-inducible factors as molecular targets for liver diseases
por: Ju, Cynthia, et al.
Publicado: (2016) -
Purinergic and Adenosinergic Signaling in Pancreatobiliary Diseases
por: Faraoni, Erika Y., et al.
Publicado: (2022) -
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
por: Luo, Zhen, et al.
Publicado: (2022) -
The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury
por: Ruan, Wei, et al.
Publicado: (2022) -
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
por: Zhao, Yongchao, et al.
Publicado: (2023)